Professional
Added to YB: 2026-04-08
Pitch date: 2026-04-02
DVYSR.ST [neutral]
Devyser Diagnostics AB (publ)
-20.85%
current return
Author Info
No bio for this author
Company Info
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
Market Cap
SEK 1.1B
Pitch Price
SEK 77.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.35
P/E
70.41
EV/Sales
4.01
Sector
Biotechnology
Category
growth
Protean Small Cap Portfolio Holding: Devyser
DVYSR.ST (holding update): Genetic testing co down 33% YTD, trading below 2021 IPO price despite nearing cash-flow breakeven & strong growth prospects. DNA-based disease risk/detection tests are sticky but slow to adopt. Market may have overestimated adoption speed.
Read full article (1 min)